• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Illumina expects EU order to keep Grail a separate company

September 20, 2021 by David Barret Leave a Comment

September 20, 2021

By Foo Yun Chee

BRUSSELS (Reuters) -Illumina Inc expects an EU order to keep recently acquired Grail Inc as a separate company, the U.S. life sciences company said on Monday, hours after EU antitrust regulators warned of interim measures for closing the deal before their approval.

The company is likely to face other measures on top of the hold separate order, however, with the EU competition enforcer sending a warning to other companies.

Illumina finalised the Grail takeover last month and said it would hold the company separate while waiting for a European Commission decision on the deal, defying EU merger rules against gun-jumping.

Previous instances of gun-jumping have resulted in companies being hit with million-euro fines. Sanctions can be as much as 10% of a company’s global turnover.

“We had anticipated that the Commission would seek to impose a hold separate order, and this is the reason why it has already voluntarily agreed to such an arrangement; their proposals are based on Illumina’s voluntary undertakings,” Illumina said in a statement.

It said it would discuss certain changes suggested by the EU in the coming days.

The EU competition enforcer earlier on Monday said it had sent a statement of objections or charge sheet to the companies, setting out the interim measures it plans to take. It did not provide details.

Under EU merger rules, the competition watchdog can order companies to unwind their deals or sell off shares or assets acquired for violations.

Commission Vice-President Margrethe Vestager underlined the seriousness of Illumina’s actions, saying it was the first time companies had openly implemented a deal while regulators were still investigating.

“The standstill obligation is a cornerstone of our ex-ante merger control regime which aims at preventing harmful effects to competition while our review is ongoing,” she said in a statement.

The Commission said the interim measures aim to restore and maintain effective competition pending a final decision on the deal.

The Commission will make a final decision on the measures after receiving the companies’ response.

(Reporting by Foo Yun Chee in BrusselsEditing by Jan Harvey and Matthew Lewis)

Source Link Illumina expects EU order to keep Grail a separate company

David Barret
David Barret

Related posts:

  1. Lebanon agrees new government to tackle economic collapse
  2. India, Australia eye closer security ties as 9/11 anniversary marked
  3. Motor racing-Mercedes boss says F1 sprint format is ‘not fish, not meat’
  4. In Hungary, pope says anti-Semitism ‘fuse’ must not be allowed to burn

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Does This Ancient Egyptian Scroll Recount The World’s Oldest Magic Trick?
  • How Come Wild Animals Don’t Have Floppy Ears? The Clue Is In Your Dog
  • 25-Year-Old Paper On Controversial Glyphosate Weedkiller Retracted, After It Turns Out Monsanto Staff Helped Write It
  • Gravitational Lenses Confirm That Something Is Still Broken In The Universe
  • Adorable Camera Trap Footage Of Moms And Cubs Heralds Conservation Win For Sunda Tigers
  • Exercise VS Sleep: Which Is More Important When You Don’t Have Time For Both?
  • A Deep-Sea Mining Test Carved Up The Seabed. Two Years On, We’re Seeing Devastating Impacts
  • Enormous New Study Finds COVID-19 mRNA Shots Associated With 25 Percent Lower Risk Of Death From Any Cause
  • What Is The Best Movie Set In Space? We Asked Real-Life Astronauts To Find Out
  • Chernobyl’s Protective Shield Is Broken After A Drone Strike, Warns UN Nuclear Watchdog
  • Isaac Newton Was Born On Christmas Day – And January 4th
  • Why Is December The 12th Month Of The Year When Its Name Means 10?
  • Poor Sauropod Was Limping When It Made Curious 360° Looping Dinosaur Track
  • Inhaling “Laughing Gas” Could Treat Severe Depression, Live Seven-Arm Octopus Spotted In The Deep Sea, And Much More This Week
  • People Are Surprised To Learn That The Closest Planet To Neptune Turns Out To Be Mercury
  • The Age-Old “Grandmother Rule” Of Washing Is Backed By Science
  • How Hero Of Alexandria Used Ancient Science To Make “Magical Acts Of The Gods” 2,000 Years Ago
  • This 120-Million-Year-Old Bird Choked To Death On Over 800 Stones. Why? Nobody Knows
  • Radiation Fog: A 643-Kilometer Belt Of Mist Lingers Over California’s Central Valley
  • New Images Of Comet 3I/ATLAS From 4 Different Missions Reveal A Peculiar Little World
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version